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Deciphering their targets and precise role, however, remains a challenge. In this study we aimed to identify miRNAs and their downstream targets involved in regeneration of islet beta cells following partial pancreatectomy in mice.
Methods:
RNA from laser capture microdissected (LCM) islets of partially pancreatectomized and sham-operated mice were profiled with microarrays to identify putative miRNAs implicated in control of beta cell regeneration. Altered expression of selected miRNAs, including miR- 
Results:
Partial pancreatectomy significantly increased the number of BrdU+/insulin+ positive islet cells. Microarray profiling revealed 14 miRNAs, including miR-132 and -141, to be significantly upregulated in LCM islets of partially pancreatectomized compared to LCM islets of control mice. In the same comparison miR-760 was the only miRNA found to be downregulated. Changed expression of these miRNAs in islets of partially pancreatectomized mice was confirmed by RT-PCR only in the case of miR-132 and -141.
Based on previous knowledge of its function, we chose to focus our attention on miR-132. 
Downregulation of miR-132

Conclusions/Interpretations:
Our study provides compelling evidence for upregulation of miR-132 being critical for regeneration of mouse islet beta cells in vivo through downregulation of its target Pten. 
Research in Context
What is already known?
• Several miRNAs, including miR-132, are known to regulate beta cell function and mass in several mouse models of diabetes db/db, ob/ob and high fat-diet.
What is the key question?
• Which are miRNAs implicated in control of beta cell regeneration upon partial pancreatectomy and how?
What are the new findings?
• miR-132 is critical to promote regeneration of mouse beta cells in vivo following partial pancreatectomy
• In vitro studies in mouse MIN6 cells indicate that miR-132 fosters beta cell proliferation by down-regulating the expression of phosphatase Pten, thereby tilting the balance between anti-apoptotic factor Akt and pro-apoptotic factor Foxo3 activities towards proliferation through regulation of their phosphorylation.
How might this impact on clinical practice in the foreseeable future?
• and -375 have been found to be relevant for beta cell function [6] . RNA sequencing of human islets detected 346 miRNAs, including 40 which were enriched in comparison to other tissues [7] . miR-375 is the most highly expressed miRNA in human and mouse pancreatic islets. Its down-regulation inhibits pancreatic islet development in Xenopus laevis [8] , while its global inactivation in mice leads to decreased beta cell mass and ultimately diabetes [9, 10] . miR-132 also plays a key role in beta cell function. Its expression is dysregulated in different mouse models of type 2 diabetes (T2D) [11] [12] [13] [14] , with its overexpression being correlated with improved glucose-stimulated insulin release from dissociated rat islet cells [13] as well as with enhanced beta cell proliferation and survival [12] [13] [14] . In primary PC12 cells, another endocrine cell model, miR-132 controls cell survival by direct regulation of Pten, Foxo3a and p300 signaling. However, in pancreatic islets, the functional relevance of miR-132 in vivo and its downstream targets remain unknown. To identify the major miRNAs as well as their downstream targets involved in beta cell proliferation, we analyzed the profile of miRNAs differentially expressed after a partial pancreatectomy in comparison to sham-operated mice. We report here that the expression of 14 miRNAs were markedly increased and one miRNA was down-regulated in islets of partially pancreatectomized mice, in which beta cell proliferation was increased. digestion to obtain a miR-132 overexpressing shuttle vector with a CMV promoter. The empty pacAd5-CMV-eGFP vector was used for the production of a control virus.
Cell culture
Mouse MIN6 cells were kind gifts from Dr. Jun-ichi Miyazaki (Osaka University, Japan), and were grown as previously described (Miyazaki et al., 1990 supplemented with 10% fetal bovine serum (Gibco), 100 U/mL penicillin, 100 U/mL streptomycin (Sigma-Aldrich) and 0.1 mM non-essential amino acids (Gibco), and were incubated at 37°C in a humified atmosphere containing 95% air and 5% CO 2 .
Adenovirus production in HEK293T Cells
The adenoviral backbone vector pacAd5-9.2-100 from the RAPAd miRNA Adenoviral Expression System (Cellbiolabs, San Diego, CA, USA) and both shuttle vectors pacAd5-CMV-eGFP and pacAd5-CMV-mir132-eGFP were PacI linearized, and co-transfected into HEK293T cells using the X-tremeGENE 9 DNA Transfection Reagent (Roche, Basel, Switzerland) and amplified, until a sufficient amount of virus supernatant was available for experiments, which was then aliquoted and stored at -80°C. Virus titers were determined with the Adeno-X TM Rapid Titer Kit (Clontech, Mountain View, CA, USA) All steps were carried out according to the manufacturer's instructions.
Altered miR-132 expression with siRNAs or with adenovirus
The single-stranded RNA used in to silence miR-132 consisted of 24-nucleotide length oligo: 5'-CGACCAUGGCUGUAGACUGUUACC-3' and as control, we used a scrambled oligonucleotide. MIN6 cells were seeded in a 6-well plate as described above on day 1.
For the silencing of miR-132, cells were transfected with 100 nM of anti-miR-132 or control siRNAs using Dharmafect4 as transfection reagent on day 2. For the overexpression of miR-132, MIN6 cells were transduced with an adenovirus in which miR-132 was driven by the CMV promoter at MOI of 6,400. On day 4 post RNA silencing or adenoviral transduction, cells were harvested proceded for BrdU labeling or western blotting as described below.
Cell extraction and immunoblotting
MIN6 cells were harvested at 4°C in RIPA buffer [50 mM Tris·HCl, pH 8.0, 150 mM NaCl, 1% Nonidet P-40, 0.1% SDS, 0.5% sodium deoxycholate, and protease inhibitor mixture (Sigma)] for total protein extraction. Insoluble material was removed by centrifugation.
Aliquots of 20 ug were separated by SDS PAGE, as described (Mziaut et al., 2008) . The source, species and dilutions of antibodies used immunoblotting are described in ESM Table 6 . Louis, MO, USA) in 50% DMSO at a rate of 0.5 µl·h -1 for 7 days. Blood glucose levels were measured daily from the tail vein with a Glucotrend glucometer (Roche Diagnostics, Basel, Switzerland).
Mouse studies
Intraperitoneal glucose tolerance test (IpGTT)
IpGTT were performed two days before surgery and six days after surgery to assess differences between wildtype and mutant mice and between pancreatectomized and sham-operated animals. After 10 hours overnight fast, mice were injected with 2.0 g/kg body weight of 20% glucose solution. Blood glucose levels were measured from the tail vein at 0, 15, 30, 60, 120 and 180 minutes after glucose injection.
The pancreatic remnants and the sham-operated pancreata were harvested 7 days postsurgery. Mice were anesthetized with isoflurane as described above and the abdominal incision was re-opened. After fixation by intracardial perfusion with 4% paraformaldehyde, mouse pancreata were removed, further fixed overnight in 10% neutral formalin, and according to the manufacturers instruction using the oligonucletides listed in ESM Table 7 .
Transcriptomic profiling of mouse islets
Total RNA was isolated from the islets of 16 -19 -week-old wild-type and miR-132 -/-mice (6 mice/group) using RNeasy (Qiagen, Hilden, Germany). For microarray analysis, 100 ng of islet RNA was amplified with the Illumina® Total Prep RNA Amplification Kit (Ambion, Inc., Austin, TX, USA) and cRNA was labeled with biotin-UTP as previously described (Mziaut et al., 2016) .
Microarray analysis and data mining
MicroArray data processing and quality control was done with GeneSpring GX 13. After quantile normalization significantly differentially expressed genes were obtained by volcano plot filtering for FC≥|1.5| and p<0.05. Functional analysis was done using Ingenuity Pathway Analysis (IPA, Qiagen, Hilden, Germany). 
Statistical analysis
Results
miR-132 is upregulated in proliferating beta cells
To identify key miRNAs involved in beta cell proliferation, we used partially pancreatectomized mice (n=3) as a model for beta cell regeneration (Fig. 1A) . The removal of 70-80% of the pancreas is a well-established procedure for inducing the replication of beta cells in the remaining pancreas [15, 16] . Proliferating cells were stained with 25µg/hr BrdU continuously delivered by an osmotic mini-pump implanted in the abdomen at the time of pancreatectomy. This approach ensures the labeling of every dividing cell [16] . As controls, 4 mice were similarly implanted with an osmotic mini-pump for BrdU delivery, but only underwent total splenectomy. Seven days post-surgery, all mice were sacrificed, their pancreas excised for serial sectioning (40 sections/mouse) and staining with cresyl-violet to locate the islets. Adjacent, unstained sections were then used to count BrdU + cells in the islet cores, which in rodents consists mainly of beta cells [15] ( Fig. 1B and C) prior to islet core excision by laser capture microdissection (LCM) ( Fig. 1 A and B). As expected, in partially pancreatectomized mice the fraction of islet core BrdU + cells/total islet core cells, as determined by nuclear counting, was significantly higher than in sham-operated mice (Fig. 1C) . RNA extracted from LCM islet cores was then profiled using microarrays. Fourteen miRNAs were found to be differently expressed (cut-off values: p= 0.05; FC≥1.5) in the islet cores of partially pancreatectomized mice compared to sham operated mice (Table 1 ). All these miRNAs were up-regulated, except miR-760, which was reduced by 2.28 fold. Expression levels of all 14 differentially expressed miRNAs were further quantified by real-time PCR (RT-PCR). With this analysis, only the significant changed expression of miR-132 and miR-141 could be validated (ESM Table   1 ). Given the role of miR-132 in the cell replication in vitro of primary islet cells [13] , and other cell types, including glioma cells [17] and epidermal keratinocytes [18] , we focus our attention on the potential involvement and mode of action of miR in the regulation of beta cell proliferation.
miR-132 affects proliferation and survival of insulinoma MIN6 cells
At first, we down-regulated miR-132 expression in mouse insulinoma MIN6 cells using an anti-microRNA approach [19] . Reduced expression of miR-132 by 90% (n=3, Fig. 2A (Fig. 2B and C) . miR-132 depletion correlated also with increased detection of cleaved Caspase-9 (n= 6; Fig. 2D and E) , while the levels of cleaved Caspase-3 were not significantly changed. Conversely, overexpression of miR-132 with a bi-cistronic adenovirus vector encoding also for eGFP (n= 3 Fig. 2F ) was not associated with a further increase in the proliferation of MIN6 cells, presumably due to their neoplastic state (n= 3, Fig. 2G and H). However, overexpression of miR-132 correlated with reduced levels of pro-and cleaved Caspase-9 (n= 6, Fig. 2I and J), consistent with miR-132 being anti-apoptotic. Table   3 ). Further analysis of regulated genes with Ingenuity Pathway Analysis revealed 8 regulated pathways (Fig. 3B and ESM Table 4 ), which included 26 of the 345 differentially expressed genes (Fig. 3C ). Among these 26 differentially expressed genes, the top 10 most represented genes in the 8 signaling pathways were selected for further validation of their mRNA levels by RT-PCR (ESM Table 5 ). As control, we also assessed the mRNA expression levels of Rasa1, an established target of miR-132 (Anand et al., 2010). As shown in Fig. 3D, 6 out of 10 of the selected genes, namely Mapk1/Erk2, Pten, Nras, Pik3r1, Gnb1 and Gnb5 were confirmed to be downregulated upon miR-132 overexpression. Three of them, Mapk1, Pten and Gnb1, were also among the 37 predicted targets for miR-132 binding (ESM Table 6 (Fig. 4A and B) , while mRNA levels of Akt were unchanged (ESM Fig. 1 ). Furthermore, levels of the Akt1 substrate Creb and phospho-Creb (S133) were unchanged, but the phospho-Creb/Creb ratio was also increased. Likewise, overexpression of miR-132 correlated with reduced expression of Mapk1/Erk2, phosphoMapk1/Erk2 and Rasa1/RasGAP, but not of Erk1 and phospho-Erk1 ( Fig. 4C and D) .
As down-regulation of miR-132 correlated with elevated cleaved Caspase-9 levels, we further tested whether its overexpression affected the expression of Foxo3a, a key mediator of apoptosis. Immunoblotting for Foxo3a showed that its phosphorylation, which inhibits its activity,was increased ( Fig. 4E-F) , although the overall levels of its mRNA (ESM Fig. 1 ) and protein ( Fig. 4E-F) were not changed.
Impaired beta cell proliferation in miR-132 knock-out mice
Finally, to verify that miR-132 positively affects beta cell regeneration in vivo, we investigated beta cell proliferation in partially pancreatectomized or sham operated miR-132 -/-mice and control littermates (6 mice/group), as described previously (Mziaut et al., 2008) . Intraperitoneal glucose tolerance test prior and 6 days after surgery showed no difference between control and miR-132 -/-mice ( Fig. 5A and B) . Daily blood glucose measurements, in particular, showed a comparable slight decrease of glycaemia in partially pancreatectomized wild-type and miR-132 -/-mice relative to sham operated mice in the first day post-surgery, followed by a complete normalization of glycaemia by the end of the 1-week-long protocol (ESM Fig. 2 ). Seven days after surgery, the mice were sacrificed, the remnant pancreas excised, (Fig. 5G , Table 2 ). These data provide conclusive evidence for miR-132 exerting a positive role for beta cell regeneration in-vivo. In conclusion, we have discovered a miRNA that acts as sensor of external changes and controls the major signaling pathway regulating cell proliferation and survival at their node.
Efforts to develop targeted therapies have not been fully successful, mainly because of extensive networking between pathway suppressors. Thus, our findings suggest that miR-132 could be a suitable candidate for therapeutic intervention to prevent beta cell damages and death as well as in improving beta cell regeneration. Moreover, The identification of a number of targets allowed us to propose mechanisms by which miR-132 is involved in these processes and eventually, could set up the ground toward the identification of the extracellular signal and the biological processes that favors a signaling pathway over another one in future studies.
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